Daily Briefing · Issue №006 · 2026-05-20

Digital Health

Clinical trial flaws ‘being scaled, not solved’ by AI: report

• Clinical trial data company Phesi’s new analysis found that fewer than one in three trial protocols are connected to documented patient data and outcomes, highlighting the risk that flawed decision-making may be repeated

FierceBiotech ↗

Pharmacy

Facing mounting China licensing costs, biopharma buyers turn to AI and local know-how to keep up

• Chinese companies now represent 50% of global out-licensing deals, with U.S. companies dropping to about 28%, according to SynBioBeta data.

FierceBiotech ↗